Please login to the form below

Not currently logged in
Email:
Password:

Aesica to buy UCB's German/ Italian sites

Leading UK pharmaceutical manufacturer, Aesica, has agreed to acquire UCB's manufacturing businesses in Germany and Italy

UCB and Aesica have agreed that Aesica will acquire current UCB manufacturing businesses in Germany and Italy.

The agreement includes the manufacturing sites in the German cities of Monheim and Zwickau, as well as Pianezza in Italy, and is part of UCB's strategy to optimise its manufacturing network in line with the evolution of its portfolio. The move will also secure the long-term supply of UCB's products and a future for the sites and their employees, according to UCB CEO Roch Doliveux.

Doliveux stated: "UCB's product portfolio has been changing significantly, which reduced UCB's need for large manufacturing capacity for chemical entities, while increasing its biotech requirements."

Approximately 600 employees in the three affected sites will be transferred to Aesica.

CEO of Aesica, Dr Robert Hardy, said: "The acquisition of the three manufacturing sites from UCB is strategically crucial for Aesica as we extend and enhance our current offering and presence in Europe. We hope to fully utilise the expertise and knowledge across the current team at UCB to achieve our vision of becoming the leading supplier of formulated products and active pharmaceutical ingredients to the global pharmaceutical and biotechnology industries.”

Subject to antitrust clearance, closing is expected for the first quarter of 2011. UCB's financial outlook for 2010 remains unchanged.

15th December 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE
NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE The bold digital clock featured on the EUGDPR (EU General Data Protection Regulation)1 website indicates – to the second...
Health knowledge: Why is it so important?
Health knowledge plays an important role in population health, but by itself is rarely enough to prompt a change in the behaviours that cause the risks....
Personas: a top tool for personalising pharma marketing campaigns
Healthcare customers are calling for greater personalisation in care from providers. Here, we explain why personas are the top tool for ensuring your brand meets this need efficiently and effectively....

Infographics